SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-042986
Filing Date
2013-08-05
Accepted
2013-08-05 16:09:07
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v350439_10q.htm 10-Q 615135
2 EXHIBIT 31.1 v350439_ex31-1.htm EX-31.1 11383
3 EXHIBIT 32.1 v350439_ex32-1.htm EX-32.1 4127
  Complete submission text file 0001144204-13-042986.txt   12715970

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20130630.xml EX-101.INS 978451
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20130630.xsd EX-101.SCH 70935
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20130630_cal.xml EX-101.CAL 26767
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20130630_def.xml EX-101.DEF 230273
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20130630_lab.xml EX-101.LAB 376352
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20130630_pre.xml EX-101.PRE 275847
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 131010334
SIC: 2834 Pharmaceutical Preparations